FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
IPO Status: Listed [9th Nov 2020 to 11th Nov 2020]
We have captured total 9 recommendations for Gland Pharma IPO. Out of 9 , 6 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 0 for Avoid and 0 hasn't given any rating. In terms of percentage 66.67% institutes has rated Gland Pharma IPO for subscribe.
Here we have covered Gland Pharma IPO Notes from Research Analysts and provided you their recommendations. These research notes will give you 360 degree view of Gland Pharma IPO. Some research analysts give clear recommendations and some left decision on you with complete analysis. We try to add the information as on when we receive the document.
Zerodha Trade@20
Gland Pharma IPO details includes issue size, issue price, discount information, minimum and maximum order quantity, promoters holding details, NSE and BSE code.
IPO Details | Values |
---|---|
IPO IPO Open Date | 9th Nov 2020 |
IPO IPO Close Date | 11th Nov 2020 |
IPO Issue Size | Aggregating up to ₹6,479.55 Cr |
IPO Issue Price | ₹1490-1500 |
Market Lot | 10 Shares |
Latest and updated information about Gland Pharma IPO. Dates are updated as they are announced.
IPO Activity | Date |
---|---|
IPO IPO Open Date | 9th Nov 2020 |
IPO IPO Close Date | 11th Nov 2020 |
Basis of Allotment Finalisation Date* | 17th Nov 2020 |
Refunds Initiation* | 18th Nov 2020 |
Credit of Shares to Demat Account* | 19th Nov 2020 |
IPO Listing Date* | 20th Nov 2020 |
* - Tentative Dates
Last Updated on 2021-01-30T23:21:59+00:00